We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

EME:NYSEEMCOR Group, Inc. Analysis

Data as of 2026-06-18 - not real-time

$842.70

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

EMCOR Group (EME) trades at $842.7, comfortably above its 20‑day SMA (≈$833) but below the 50‑day SMA (≈$856), suggesting a short‑term pull‑back potential. Technicals show a neutral trend, an RSI of ~51 and a bullish MACD histogram (+$1.45) that supports modest upside toward the $879 resistance. The stock’s volatility is high at 33% over the past 30 days and beta exceeds 1.1, indicating sensitivity to market swings. Fundamentally, revenue is expanding at a robust 19.7% YoY, ROE is stellar at 39%, and the payout ratio is a conservative 3.9%, making the 0.16% dividend sustainable. However, the current price is well above the DCF‑derived fair value of $605 and the PE of 28 is modestly lower than the industry average of 31, implying the market is pricing in strong growth expectations. Recent coverage highlights EMCOR’s rapid growth in data‑center cooling and Oppenheimer’s new Outperform rating, reinforcing the growth narrative but also adding to valuation pressure.
Overall, while the company’s cash generation, low leverage and expanding infrastructure opportunities underpin a positive outlook, the elevated valuation, high volatility and decreasing volume suggest a cautious stance, especially in the near term.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price near resistance with decreasing volume
  • Bullish MACD histogram but neutral trend
  • Overvaluation relative to DCF fair value

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Strong revenue growth (~20% YoY) and high ROE
  • Low payout ratio and sustainable dividend
  • Positive analyst coverage and growth in data‑center cooling

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • Robust cash flow and modest leverage
  • Long‑term infrastructure and renewable energy demand
  • Consistently high return metrics despite premium valuation

Key Metrics & Analysis

Financial Health

Revenue Growth19.70%
Profit Margin7.54%
P/E Ratio28.3
ROE39.23%
ROA11.75%
Debt/Equity13.36
P/B Ratio9.7
Op. Cash Flow$1.2B
Free Cash Flow$891.5M
Industry P/E31.5

Technical Analysis

TrendNeutral
RSI50.7
Support$775.88
Resistance$879.37
MA 20$833.04
MA 50$855.64
MA 200$725.43
MACDBullish
VolumeDecreasing
Fear & Greed Index91.13

Valuation

Fair Value$604.74
Target Price$1,000.14
Upside/Downside18.68%
GradeOvervalued
TypeBlend
Dividend Yield0.16%

Risk Assessment

Beta1.74
Volatility33.14%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.